- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01037569
Optimizing Toxicological Screening in Drug Endangered Children
Background:
- Children who enter the foster care system are all too often exposed to illicit drugs in the home. Children from these homes, known as drug endangered children, are not routinely tested for harmful substances. Any short- and long-term physical or developmental problems they may experience as a result of this exposure often go undetected and untreated.
- Children who are placed into protective custody are not always screened by physicians or nurse practitioners. Although drug-endangered children under 18 years of age automatically receive a urine toxicology screen to determine the types and levels of illicit drugs in their systems, this procedure has difficulties and limitations that may affect the quality of the data. Researchers are interested in developing more effective methods of analyzing the presence or absence of illicit environmental drug exposure in children.
Objectives:
- To determine the most effective method of identifying long-term illicit stimulant drug exposure in drug-endangered children.
Eligibility:
- Children under 18 years of age who are being placed into protective custody after having been found in a home where drugs are manufactured, used, or sold.
Design:
- Researchers will gain verbal consent for the procedure for children who are 7 years of age or older. Children younger than 7 years of age will not be required to give verbal consent for sample collection.
- Researchers will collect standard urine samples for toxicological screening. Part of the sample will be sent to the National Institute on Drug Abuse for evaluation; the rest will remain with the local authority.
- In addition to this standard procedure, researchers will collect a hair sample by cutting a small amount of hair from the crown of the head as close to the root as possible (and not pulling any hair out of the child's head).
- Researchers will also use an oral swab to collect a saliva sample from the inside cheek of each child.
- No clinical care will be provided under this protocol....
Přehled studie
Postavení
Podmínky
Detailní popis
Typ studie
Zápis (Očekávaný)
Kontakty a umístění
Studijní místa
-
-
California
-
Davis, California, Spojené státy, 95616
- University of California, Davis
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
- ELIGIBILITY CRITERIA:
Inclusion criteria are the following (and must have all of the following):
- children under the age of 18 (the vast majority - 87 percent - of children examined at the Center are under the age of 6);
- children placed into protective custody by Sacramento County CPS or law enforcement;
- children examined at the CAARE Center; and
- children found in a home where drugs are manufactured, used and/or sold.
Exclusion criteria are the following (any one of the following may apply):
- anyone who has reached the age of majority;
- those found to have parents who are not drug abusers;
- those where there was no definitive evidence of environmental drug exposure (i.e., suspicious parent, but no drugs were found in the home); or
- any child, drug exposed or not, who is examined in the UCD Emergency Department (after hours - 9:00 pm to 7:00 am - and weekends).
Studijní plán
Jak je studie koncipována?
Detaily designu
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 999907431
- 07-DA-N431
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Detekce zneužívání látek
-
University Hospital, Clermont-FerrandDokončeno
-
Peking Union Medical College HospitalDokončenoNanopore HPV integrační místo třetí generace pro přesnou předpověď prognózy rakoviny děložního čípkuRakoviny děložního čípku | Testování HPV | Sekvenování nanoporů | HPV Integration Site Detection | Rychlá diagnostikaČína